OMass Therapeutics Teams Up with Genentech on First‑in‑Class IBD Oral Small Molecule
OMass Therapeutics, a biotechnology firm that discovers medicines targeting membrane proteins and intracellular complexes, has...
OMass Therapeutics, a biotechnology firm that discovers medicines targeting membrane proteins and intracellular complexes, has...